Background The relationship of social determinants of health (SDOH), environmental exposures and medical history to lung function trajectories is underexplored. A better understanding of these ...

TIMES SQUARE, Manhattan -- A new threat assessment for Times Square on New Year's Eve is pointing to lone wolves and small groups. ABC News has obtained a copy of a report which was compiled by the ...

SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a novel approach to chronic pain management and joint tissue preservation.

Warm water and air and unusual weather conditions tracing back as far as tropical cyclone flooding in Indonesia helped supercharge stubborn atmospheric rivers that have drenched Washington state with ...

Five9 shares continue to face pressure as investors weigh concerns about decelerating growth. The contribution from AI revenue is increasing, with solid momentum in AI bookings growth. Adjusted EBITDA ...

Visa presents a rare opportunity to buy a high-quality stock at a reasonable valuation after years of underperformance. V benefits from the shift to cashless transactions, persistent inflation, and ...

America’s middle class is weary. After nearly five years of high prices, many middle-class earners thought life would be more affordable by now. Costs for goods and services are 25% above where they ...

BREAKING NEWS. LET’S GO LIVE TO THE NTSB UPDATE ON THE DEADLY PLANE CRASH FAMILY. THOSE THAT HAVE BEEN AFFECTED BY THIS, WE KNOW AS EACH DAY IT GOES A LITTLE BIT FARTHER, IT BECOMES A LOT TOUGHER.

America has a chronic pain problem. While there has been increased attention, in both policy and drug development, on non-opioid treatments, the focus has been on managing acute pain. The current ...

Medications may include NSAIDs, acetaminophen or other non-opioid drugs. “I do not prescribe tramadol for chronic pain. Period. The risks are clear from this study,” Schwartz said. “The real tragedy ...

Novartis has scored the FDA’s approval for a second BTK inhibitor that’s for a non-cancer indication, teeing off a potential competition with Sanofi down the line. The FDA has blessed Novartis’ ...

A specially produced compound from the cannabis plant has dramatically helped people suffering with long term back pain according to scientists in Germany. They say a 12 month clinical trial of over ...